首页> 外文OA文献 >Indomethacin (INC) Pharmacokinetics in Extremely Premature Infants who Receive Prophylactic (P) ICN in the First 24H of Life for Prevention of Patent Ductus Arteriosus (PDA) • 991

【2h】

Indomethacin (INC) Pharmacokinetics in Extremely Premature Infants who Receive Prophylactic (P) ICN in the First 24H of Life for Prevention of Patent Ductus Arteriosus (PDA) • 991

机译：Indomethacin（Inc）药代动力学在最早的婴儿中获得预防性（P）ICN的预防性（P）ICN，用于预防专利导管术（PDA）•991

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Robert J Couser; Michele M Marshall; T Bruce Ferrara; Gregory B Wright; Allison K Cabalka; Don L Uden;
展开▼
作者单位

展开▼
年度 1998
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes [J] . Melissa Liebowitz, Ronald I. Clyman The Journal of pediatrics . 2017,第期

机译：预防性吲哚美辛与极端早产儿专利导管的延迟保守管理相比：对新生儿结果的影响
2. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. [J] . Fujii AM, Brown E, Mirochnick M, Journal of perinatology: Official journal of the California Perinatal Association . 2002,第7期

机译：接受早期消炎痛治疗动脉导管未闭的极早产儿的新生儿坏死性小肠结肠炎肠穿孔。
3. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels. [J] . ODonovan DJ, Fernandes CJ, Nguyen NY, American Journal of Perinatology . 2004,第4期

机译：吲哚美辛治疗早产儿动脉导管未闭：基于第二剂量峰值血浆吲哚美辛水平和估计血浆吲哚美辛水平的给药策略的有效性。
4. An Enhanced Approach for the Prioritisation in Patent Ductus Arteriosus (PDA) Services Using Data Mining Techniques [C] . Noura Alzeer, Hessah A. Alsalamah, Alaaeldin Hafez International Conference on eHealth, Telemedicine, and Social Medicine . 2018

机译：使用数据挖掘技术的专利导管arteriosus（PDA）服务优先考虑的增强方法
5. Patent ductus arteriosus management in premature neonates weighing 1000-2000 grams: A comparison of prophylactic closure, clinically-indicated closure, and supportive care. [D] . Tawil, Yehudis Rivka. 2012

机译：重达1000-2000克的早产儿动脉导管未闭的管理：预防性封闭，临床指示性封闭和支持治疗的比较。
6. Prophylactic indomethacin compared with delayed conservative management of the patent ductus arteriosus in extremely preterm infants: effects on neonatal outcomes [O] . Melissa Liebowitz, Ronald I. Clyman -1

机译：在极早产儿中预防性消炎痛与延迟动脉导管未闭的保守治疗相比：对新生儿结局的影响
7. RELATIONSHIP OF SERUM INDOMETHACIN (ICN) LEVELS TO DUCTUS ARTERIOSUS CLOSURE IN EXTREMELY PREMATURE INFANTS TREATED WITH PROPHYLACTIC INDOMETHACIN.† 1202 [O] . Robert J Couser, Craig G Schilling, T Bruce Ferrara, 1996

机译：血清吲哚美辛（ICN）水平与预防性吲哚美辛治疗的极早婴幼儿闭合的关系。†102

Indomethacin (INC) Pharmacokinetics in Extremely Premature Infants who Receive Prophylactic (P) ICN in the First 24H of Life for Prevention of Patent Ductus Arteriosus (PDA) • 991

著录项

相似文献

相关主题

期刊订阅